Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 43 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 8680065

    Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  2. US 8673316

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  3. US 8673333

    Cross-linked polymer matrices, and methods of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  4. US 8663622

    Recombinant vaccine viruses expressing IL-15 and methods using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  5. US 8664183

    SPANX-B polypeptides and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  6. US 8652787

    Use of ERBB4 as a prognostic and therapeutic marker for melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  7. US 8647818

    Molecular scaffolds for HIV-1 immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services (Hereinafter the Government) Office of Technology Transfer, National Institutes of Health · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  8. US 8637050

    Peptide vaccines against group A streptococci

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  9. US 8637310

    Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  10. US 8637036

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  11. US 8636978

    Cyclized NGR peptide compounds, compositions, and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  12. US 8633177

    Nitroxyl (HNO) releasing compounds and uses thereof in treating diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  13. US 8632782

    Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  14. US 8628962

    Differentiation of stem cells into dopaminergic cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  15. US 8618090

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  16. US 8614304

    Immunogenic peptides and methods of use for treating and preventing cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Serives · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  17. US 8613933

    Brachyury polypeptides and methods for use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  18. US 8613934

    Cellular and viral inactivation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  19. US 8613932

    GP100-specific T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  20. US 8609716

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  21. US 8609395

    Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  22. US 8603978

    Use of muramyl dipeptide (MDP) for treating inflammation

    The United States of America, as represented by the Secretary, Department of Health and Humand Services · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  23. US 8597883

    Biomarkers for cancer-related fatigue and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  24. US 8597660

    Therapeutic approach to neurodegenerative disorders using a TFP5-peptide

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.